Guardian Investment Management trimmed its holdings in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 0.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 11,141 shares of the computer hardware maker’s stock after selling 50 shares during the quarter. NVIDIA makes […]
Guardian Investment Management decreased its holdings in shares of Intel Co. (NASDAQ:INTC – Free Report) by 2.6% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 103,610 shares of the chip maker’s stock after selling 2,749 shares during the quarter. Intel comprises about 4.3% of […]
Guardian Investment Management decreased its position in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 1.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 17,700 shares of the company’s stock after selling 300 shares during the quarter. Merck & […]
Guardian Investment Management lessened its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 22,121 shares of the company’s stock after selling 700 shares during the period. AbbVie comprises approximately 2.8% of […]
Guardian Investment Management lessened its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 12,750 shares of the healthcare product maker’s stock after selling 200 shares during the quarter. […]